Professor Gottfried Kremsner injects a vaccination against the coronavirus disease (COVID-19) from German biotechnology company CureVac to a volunteer at the start of a clinical test series at his tropical institute of the university clinic in Tuebingen, Germany, Jun 22, 2020. REUTERS/FILE

India approves Itolizumab to treat virus patients

The ‘first-in-class’ drug, produced by Indian firm Biocon Ltd, will save lives and help reduce the mortality rate in India, DCGI Chief Mazumdar-Shaw says